Jerome Stevens Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Jerome Stevens Pharmaceuticals, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include TRITHROID, UNITHROID, and THYQUIDITY. The owner is based in Bohemia, NY.

60 Davinci Drive

Bohemia, NY 11716

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TRITHROID
TRITHROID
Registered 2015
THYROX
THYROX
Cancelled 1999
JSP
JSP
Cancelled 1999
UNITHROID
UNITHROID
Registered 1999

Trademark Classifications

Jerome Stevens Pharmaceuticals, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jerome Stevens Pharmaceuticals, Inc. have?

Jerome Stevens Pharmaceuticals, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 2 cancelled.

What trademark classes does Jerome Stevens Pharmaceuticals, Inc. file in?

Jerome Stevens Pharmaceuticals, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jerome Stevens Pharmaceuticals, Inc.'s most well-known trademarks?

Jerome Stevens Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as TRITHROID, UNITHROID, and THYQUIDITY. These are among 3 currently registered trademarks in the portfolio.

What is Jerome Stevens Pharmaceuticals, Inc.'s trademark registration success rate?

Jerome Stevens Pharmaceuticals, Inc. has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.